New Insights into the Mechanisms of Action of Topical Administration of GLP-1 in an Experimental Model of Diabetic Retinopathy

Neurodegeneration in diabetic retinopathy: does it really matter?

(2018) Rafael Simó et al.   DIABETOLOGIA

Regulation of Brain-Derived Neurotrophic Factor and Growth Factor Signaling Pathways by Tyrosine Phosphatase Shp2 in the Retina: A Brief Review

(2018) Mojdeh Abbasi et al.   Frontiers in Cellular Neuroscience

Global Estimates on the Number of People Blind or Visually Impaired by Diabetic Retinopathy: A Meta-analysis From 1990 to 2010

(2016) Janet L. Leasher et al.   DIABETES CARE

Sitagliptin inhibits endothelin-1 expression in the aortic endothelium of rats with streptozotocin-induced diabetes by suppressing the nuclear factor-κB/IκBα system through the activation of AMP-activated protein kinase

(2016) SONG-TAO TANG et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

PI3K/AKT signaling mediated by G protein-coupled receptors is involved in neurodegenerative Parkinson's disease (Review)

(2016) Noriko Nakano et al.   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE

Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control

(2016) Young-Sun Lee et al.   MEDIATORS OF INFLAMMATION

Diabetic retinopathy

(2016) Tien Y. Wong et al.   Nature Reviews Disease Primers

Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes

(2015) Cristina Hernández et al.   DIABETES

GLP1 protects cardiomyocytes from palmitate-induced apoptosis via Akt/GSK3b/b-catenin pathway

(2015) Ying Ying et al.   JOURNAL OF MOLECULAR ENDOCRINOLOGY

Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence

(2015) Rafael Simó et al.   PROGRESS IN RETINAL AND EYE RESEARCH

The DPP-4 inhibitor sitagliptin attenuates the progress of atherosclerosis in apolipoprotein-E-knockout mice via AMPK- and MAPK-dependent mechanisms

(2014) Yanmei Zeng et al.   Cardiovascular Diabetology

The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration

(2014) David Heras-Sandoval et al.   CELLULAR SIGNALLING

The db/db Mouse: A Useful Model for the Study of Diabetic Retinal Neurodegeneration

(2014) Patricia Bogdanov et al.   PLoS One

Neuroprotection Signaling of Nuclear Akt in Neuronal Cells

(2014) Jee-Yin Ahn   Experimental Neurobiology

Light activation of the insulin receptor regulates mitochondrial hexokinase. A possible mechanism of retinal neuroprotection

(2013) Ammaji Rajala et al.   MITOCHONDRION

Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives

(2013) Rafael Simó et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob/ob mice

(2012) W D Porter et al.   INTERNATIONAL JOURNAL OF OBESITY

Glucagon-like peptide-1 receptor activation reduces ischaemic brain damage following stroke in Type 2 diabetic rats

(2011) Vladimer Darsalia et al.   CLINICAL SCIENCE

WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death

(2010) Balachandar Venkatesan et al.   CELLULAR SIGNALLING

The Wnt /β-catenin signaling pathway in the adult neurogenesis

(2010) Lin Zhang et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Hypoxia-Induced Retinal Angiogenesis in Zebrafish as a Model to Study Retinopathy

(2008) Renhai Cao et al.   PLoS One